Puma Biotechnology | PBYI - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 2.38B 556M 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Incyte USD 585.6M 282.27M 2026-06
MacroGenics USD -36.77M 22.62M 2026-03
Moderna USD -1.34B 517M 2026-03
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY 113.2B 137.52B 2026-06
TG Therapeutics USD 7.78M 12M 2026-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06